EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma.
Hua BaiJianchun DuanChengcheng LiWenzhuan XieWenfeng FangYu XuGuoqiang WangRui WanJing SunJiachen XuXin WangKailun FeiZhengyi ZhaoShangli CaiLi ZhangJie WangZhijie WangPublished in: Journal for immunotherapy of cancer (2021)
NCC2016JZ-03, NCC2018-092.
Keyphrases